Observe Medical ASA (OBSRV.XOSL) Financials

Observe Medical ASA generated about NOK 19 million in revenue over the trailing twelve months. Revenue has grown at roughly -5.9% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Observe Medical ASA reported about -NOK 49 million in net loss over the trailing twelve months, a net margin of roughly -258.6%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

Observe Medical ASA runs a gross margin of about 25.0%, an operating margin of about -198.5%, a net margin of about -258.6%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

Observe Medical ASA's revenue has compounded at roughly -5.9% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside OBSRV.XOSL's margins and free cash flow. This is analysis from company filings, not investment advice.